We have had talks with a number of Indian firms invloved in R&D and will announce the partnership soon, said Eli Lilly and Company India chairman and managing director Rajiv Gulati. Officials from the parent company have been visiting the country frequently to finalise modalities, Mr Gulait said but declined to divulge details of the possible Indian partners and areas of cooperation.
Pointing out the need for Eli Lilly to conduct R&D In India, Gulati said there has been an exponential rise in R&D costs worldwide even as outcome of the researches has come down.
In such a scenario, India can not only provide a cost competitive advantage but also its knowledge and skilled manpower offers a promising destination for R&D, he said.
Eli Lillys global research and development arm, Lilly Systems Biology has been scouting for partners in India to collaborate in its biotechnology and biomedical projects.
It is learnt that the Singapore-based research arm has been in talks with both leading Indian drug companies and state-run research institutes and laboratories.